Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emmanuelle Gélizé"'
Autor:
Daniela Rodrigues-Braz, Linxin Zhu, Emmanuelle Gélizé, Jean-Pierre Clarin, Xavier Chatagnon, Youcef Benzine, Philippe Rampignon, Agathe Thouvenin, Jean-Louis Bourges, Francine Behar-Cohen, Min Zhao
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1446 (2023)
Abnormal corneal wound healing can compromise corneal transparency and lead to visual impairment. Mineralocorticoid receptor antagonists (MRA) are promising candidates to promote corneal remodeling with anti-inflammatory properties and lack gluococor
Externí odkaz:
https://doaj.org/article/f43ab787019f4e96b59d74911e869926
Autor:
Pierre-Raphaël Rothschild, Sawsen Salah, Marianne Berdugo, Emmanuelle Gélizé, Kimberley Delaunay, Marie-Christine Naud, Christophe Klein, Alexandre Moulin, Michèle Savoldelli, Ciara Bergin, Jean-Claude Jeanny, Laurent Jonet, Yvan Arsenijevic, Francine Behar-Cohen, Patricia Crisanti
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract In diabetic retinopathy, the exact mechanisms leading to retinal capillary closure and to retinal barriers breakdown remain imperfectly understood. Rho-associated kinase (ROCK), an effector of the small GTPase Rho, involved in cytoskeleton d
Externí odkaz:
https://doaj.org/article/8758b404d405418ca43ea07240fbe4ea
Autor:
Samy Omri, Francine Behar-Cohen, Pierre-Raphaël Rothschild, Emmanuelle Gélizé, Laurent Jonet, Jean Claude Jeanny, Boubaker Omri, Patricia Crisanti
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81600 (2013)
AIMS/HYPOTHESIS: Diabetic macular edema represents the main cause of visual loss in diabetic retinopathy. Besides inner blood retinal barrier breakdown, the role of the outer blood retinal barrier breakdown has been poorly analyzed. We characterized
Externí odkaz:
https://doaj.org/article/c65f7410bd664ed28f54eb0c84be339e
Autor:
María Marcela Barrio, Riad Abes, Marina Colombo, Gabriela Pizzurro, Charlotte Boix, María Paula Roberti, Emmanuelle Gélizé, Mariana Rodriguez-Zubieta, José Mordoh, Jean-Luc Teillaud
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Externí odkaz:
https://doaj.org/article/6063186d4c954a6191316ff2f4298ff8
Publikováno v:
Blood. 116:926-934
The anti-CD20 monoclonal antibody (mAb) rituximab has been used successfully for lymphoma therapy for more than 10 years. Although several direct mechanisms by which anti-CD20 mAbs act have been characterized in vitro, their specific role in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8096314c8b5030b3c803d471e6be12
https://doi.org/10.1182/blood-2009-10-248609
https://doi.org/10.1182/blood-2009-10-248609
Autor:
Boubaker Omri, Laurent Jonet, Francine Behar-Cohen, Emmanuelle Gélizé, Jean Claude Jeanny, Samy Omri, Pierre-Raphaël Rothschild, Patricia Crisanti
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81600 (2013)
PLoS ONE
Plos One, vol. 8, no. 11, pp. e81600
PLoS ONE
Plos One, vol. 8, no. 11, pp. e81600
Aims/hypothesis Diabetic macular edema represents the main cause of visual loss in diabetic retinopathy. Besides inner blood retinal barrier breakdown, the role of the outer blood retinal barrier breakdown has been poorly analyzed. We characterized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40bb0cb21a2725fcf46dbf16b395cfa5
http://europepmc.org/articles/PMC3843687?pdf=render
http://europepmc.org/articles/PMC3843687?pdf=render
Autor:
Jean-Luc Teillaud, Mariana Rodriguez-Zubieta, Marina Colombo, Gabriela Andrea Pizzurro, Riad Abès, Maria Marcela Barrio, Charlotte Boix, José Mordoh, María Paula Roberti, Emmanuelle Gélizé
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
PLoS ONE
PLoS ONE
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15097f8a5e17043e8aa92df44859b6c
https://doi.org/10.1371/journal.pone.0040311
https://doi.org/10.1371/journal.pone.0040311
Autor:
Min Zhao, Irmela Mantel, Emmanuelle Gelize, Xinxin Li, Xiaoyue Xie, Alejandro Arboleda, Marie Seminel, Rinath Levy-Boukris, Marilyn Dernigoghossian, Andrea Prunotto, Charlotte Andrieu-Soler, Carlo Rivolta, Jérémie Canonica, Marie-Christine Naud, Sebastian Lechner, Nicolette Farman, Irene Bravo-Osuna, Rocio Herrero-Vanrell, Frederic Jaisser, Francine Behar-Cohen
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
Current treatments for age-related neovascular macular degeneration (nAMD) suffer from limited efficacy. Here, Zhao et al. show that pharmacological inhibition or genetic deletion of the mineralocorticoid receptor (MR) limits choroidal neovascularisa
Externí odkaz:
https://doaj.org/article/38bef37aaba649d6a6734776e59801e9
Autor:
Céline Borras, Kimberley Delaunay, Yousri Slaoui, Toufik Abache, Sylvie Jorieux, Marie-Christine Naud, Mohamed El Sanharawi, Emmanuelle Gelize, Patricia Lassiaz, Na An, Laura Kowalczuk, Cédric Ayassami, Alexandre Moulin, Francine Behar-Cohen, Frédéric Mascarelli, Virginie Dinet
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A common allele (402H) of the complement factor H (FH) gene is the major risk factor for age-related macular degeneration (AMD), the leading cause of blindness in the elderly population. Development and progression of AMD involves vascular and inflam
Externí odkaz:
https://doaj.org/article/3646d397d2b940178ae9e6eb1094d66d